"Injection Consistency Evaluation" new rules announced The National Health Insurance Administration set a time limit for the settlement of fees

Wen-head sporethis week to see the point
the State Drug Administration issued a "injection consistency evaluation" new regulations
the State Health Insurance Administration: the cost settlement time limit does not exceed 30 working days
health care committee issued a clear 10 "Internet and medical services" project and related charging behavior
the rebound of the Wuhan epidemic, the outbreak testing reagent enterprise stock market surge
May 14, the State Drug Administration officially issued "on the implementation of chemical injection synthe sine quality and efficacy consistency evaluationannouncement pointed out that the listed chemical injection generic drugs, not in accordance with the original drug quality and efficacy of the principle of approval of varieties need to carry out a consistent evaluationThe holder of a drug listing license shall select the reference preparation according to the List of Generic Drug Reference Preparations issued by the State Drug Administration, and carry out a consistent evaluation of the research and development declarationhas not been included in the "generic drug reference preparation catalog" varieties, drug listing license holders should be in accordance with the "National Drug Administration on the issuance of chemical generic drug reference preparation selection and determination procedures" (No25 of 2019) to declare the reference preparations, pending the determination of the reference preparations to carry out a consistent evaluation of research and development declaration, to avoid the occurrence of reference preparation selection and national publication of the reference preparations, affecting the development of resources and other issuesa generic drug for chemical softos that are clearly of clinical value but cannot be determined, such as sodium chloride injections, glucose injections, sodium glucose chloride injections, and water injections, etc., does not require a consistency evaluationOn May 12, the State Health Insurance Administration issued a Notice on the Issue of the National Medical Security Administration's List of Government Services (hereinafter referred to as the "National List"), which is divided into 10 main items and 28 sub-items, the time limit for the settlement of the expenses of the designated medical institutions (including medical institutions and retail pharmacies) shall not exceed 30 working daysIt is hoped that the problem of the settlement of medical insurance expenses of fixed-point medical institutions will be solved and the pressure of capital flow should be reducedAt the same time, for the current medical security management of government services in the field of the existence of the process is not simplified norms, the transfer of insurance and manual reimbursement procedures cumbersome and long time cycle, off-site medical filing is not convenient, the experience of handling services is not ideal and other issues put forward new requirements"National List" covers the current medical security handling of the ten general service matters, has clearly handled the time limit of 26 sub-items, processing time limit than before the actual processing time limit has been greatly reduced, the overall compression ratio of more than 50% so that, by reducing the time limit for medical insurance settlement, the implementation of medical insurance fund advance, supervision of medical institutions timely repayment, the problem of arrears will be improved, reduce the pressure on the operation of enterprise funds And by the health insurance department and pharmaceutical companies to settle the money directly, will solve the triangular debt between hospitals, pharmaceutical companies, medical insurance May 12, the State Medical Insurance Administration issued the "Interim Measures for the Administration of Drug Use of Basic Medical Insurance (Draft for Comments)" deadline for comments pointed out that the state medical security administrative department has established and perfected the dynamic adjustment mechanism of the Basic Medical Insurance Drug Catalog, which in principle adjusts once a year Not long ago, Shanghai Sunshine Pharmaceutical Procurement Network published 20 negotiated prices higher than the lowest price of five provinces and cities of the list of drugs and 10 "National Drug Supply Guarantee Integrated Management Information Platform" without the price information of the provinces and cities of the list of drugs, and made it clear that if the production enterprises can not prove its reasonable price, will suspend the internet qualification , Beijing, Tianjin, Shandong, Sichuan and Hunan have announced the list of drugs transferred out of the medical insurance catalogue Hebei, Jiangxi, Anhui and other provinces will also be transferred in three years according to different proportions (40%, 40%, 20%), the drugs transferred out of the medical insurance list must be paid for by individuals so, the worst outcome of the focus on monitoring varieties is to bring up the health-care catalog Not being in the health-care list is certainly a great disadvantage, but it doesnot mean hopeless Unless willing to withdraw from the market, otherwise the relevant enterprises not only have to die and live the determination, but also have practical methods and strategies on May 14, the National Administration of Traditional Chinese Medicine of the National Health and Health Commission (NSC) issued the Notice on the Technical Specifications and Financial Management of the "Internet and Medical Services" Project of Public Medical Institutions Part 1 puts forward the management requirements of the "Internet plus Medical Services" project The 10 "Internet and Medical Services" projects have been identified, and the charging behavior of medical institutions to carry out related services has been standardized Part 2 puts forward the accounting and financial management requirements of "Internet and Medical Services" The distribution relationship of benefits, revenue recognition principle, financial processing and bill processing requirements of different subjects in the process of carrying out "Internet and medical services" are clarified Part 3 puts forward the workload statistics requirements after the implementation of "Internet plus medical services" After the inviting and inviting parties carry out the "Internet plus medical service", the workload statistics standards within the medical institutions and within the overall region are clarified Part 4 annex clearly defined the "Internet and Medical Services" project technical specification content, based on the "Internet Diagnostic and Therapeutic Management Measures (Trial)", "Internet Hospital Management Measures (Trial)" and "Remote Medical Service Management Code (Trial)" in the relevant technical requirements for clinical access on May 12, , the Medical Treatment Group of the State Council's Joint Prevention and Control Mechanism for The New Coronary Pneumonia Outbreak issued a Notice on the Promotion of Work Experience in the Construction and Management of Shanghai Fever Outpatient Clinics to promote the work experience of the Shanghai Health and Health Commission in responding to the outbreak to the whole country notice indicates that hospitals at all levels should increase the configuration of fever clinics, should increase the number of medical personnel, such as internal medicine, emergency, imaging and other medical personnel, as well as related medical equipment document in particular pointed out that to gradually increase the CT configuration of fever outpatient, for the fever outpatient imaging examination capacity is insufficient, should be graded and gradually built, in accordance with the "first suburban hospital after urban hospital, first second-level hospital after the third-level hospital" principle configuration CT, equipment in stages to complete the installation at present, CT imaging results are an important reference standard for doctors as clinical diagnosis, and on the basis of CT scan, it is possible to predict recurrence in combination with AI on the clinical performance of patients Michael Ryan, who heads WHO's health emergency program, said wednesday that the new coronavirus could be a long-term problem, and it is difficult to predict when it will be defeated, and that it could become an epidemic that will never go away Michael Ryan says he hopes to develop a highly effective vaccine that will be distributed to everyone in the world May 12, Anhui Provincial Drug Administration issued a january-April 2020 drug production supervision and inspection information notice, of which, there are due to fly inspection: 2; May 12, Shandong Province issued a notice on the Prevention and Control program of Chinese medicine for new coronavirus pneumonia in Shandong Province (hereinafter referred to as the Program) The prevention and treatment of new coronaviruses are also proposed is worth noting that the Program in the treatment of a number of traditional Chinese medicine, including fennel positive gas (soft) capsules (pills, water, oral liquid), lianhua clear plague capsules (particles), golden flower clear particles, blue tantalum oral liquid, hydrophobic detoxification capsules (particles) and more than a dozen drugs Luo Xin Pharmaceutical's 7.5 billion yuan "backshell" listing behind, there are money-making pioneers, but also are facing pressure on the latter The more crucial protagonist is Luo Xin Pharmaceuticals itself, whose shell after the listing of the test has just begun May 12, Dongyin shares announced that the securities short will be officially renamed "Roxin Pharmaceuticals." This means that from May 2019, Luoxin Pharmaceutical "shell" Dongyin shares listed, finally have the results in fact, as early as December 31 last year, the China Securities Regulatory Commission has approved the listing of Luoxin Pharmaceuticals' shell Dongyin shares, this time only the end of the name Luo Xin Pharmaceuticals, a former GEM listed company on the Hong Kong Stock Exchange, applied to the Hong Kong Stock Exchange several times in February 2013, November 2013 and December 2015 to switch to the main board transaction, but this was rejected May 11, Wuhan New Crown Pneumonia Outbreak Prevention and Control Command epidemic-related big data and epidemiology investigation team issued "on the implementation of the city's new coronavirus nucleic acid screening "emergency notice" (hereinafter referred to as "emergency notice"), which informed Wuhan District New Coronary Pneumonia Outbreak Prevention and Control Command: after research decision, in Wuhan City-wide to carry out a full new coronavirus nucleic acid screening "10-day General Assembly War." Each district according to the 10-day period, do a good job in this jurisdiction of the full nucleic acid screening program arrangements 12 morning, the new crown pneumonia monitoring concept rose alarmingly, the index straight below 4%, as of May 12, the close, Mike Bio, Nine Biology, Mingde Biological and many other ups and downs, Da'an gene rose more than 9%, Shushi Bio, Huada gene and other stocks have also pulled up 13, the concept gradually digested, the extent of the closing increase called the previous day's decline significantly, Mingde, Huada, Da'an and other three enterprises fell seriously, while in the previous few days in Hubei Province announced the new corona pneumonia nucleic acid testing reagents in the winning enterprises only Mike biostock market still showed last week's trend